LXRP Issues Game Changing News

Recommended Stock Newsletters
 
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder

SmallCapVoice Newsletter

BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.

=================================================================

LXRP Issues Game Changing News —————————————————————– Hot Stock to Watch —————————————————————– Company: Lexaria Corp. (OTCQB: LXRP) Close:

Price: 0.102 Change (%): + 0.007 (7.37) Volume: 371,808 http://app.getresponse.com/click.htmlx=a62b&lc=VYu8w&mc=BT&s=V2HFR&u=BEqW&y=2& Lexaria Oilfield Sale Completed KELOWNA, BC / ACCESSWIRE / December 10, 2014 / Lexaria Corp.

(OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is pleased to announce the sale of all its Belmont Lake oil assets for 1.4 million dollars in cash has closed and all money received.

Lexaria congratulates the new owners for having purchased a fine asset.

Lexaria has now repaid all outstanding debts. As a result our monthly expenditures have decreased and we are no longer making interest or principal repayments.

“We are very excited about using our new cash reserves to launch PoViva Tea and pursue our alternative-health business plan,” said Chris Bunka, CEO of Lexaria.

Lexaria is working almost around-the-clock to be able to offer PoViva tea to consumers as quickly as possible. We are hoping to be able to announce our ability to accept pre-orders before Christmas.

We are close to unveiling our new 1st generation PoViva website with an announcement pending in the days to come.

Lexaria is asking all its shareholders to spread the word of PoViva Tea and our patent pending process of delivering CBD, in preparation for sales to commence. We also remind all concerned that the CBD-oil derived from agricultural hemp that PoViva uses is legal in all 50 states and never contains more than inconsequential amounts of THC; less than 0.3%.

Continue Reading – http://app.getresponse.com/click.htmlx=a62b&lc=VYujT&mc=BT&s=V2HFR&u=BEqW&y=h& —————————————————————– IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY —————————————————————– SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies.

You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research.

You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. opt out of our distribution list at any time by clicking on the “

 
This entry was posted in SmallCapVoice and tagged . Bookmark the permalink.

Comments are closed.